Case Studies

Webinars & Presentations

Experience Matters: Creative Solutions to Overcome Challenges in Antibody Drug Discovery

Watch as we present data highlighting some of our antibody discovery approaches for challenging targets to yield diverse leads.


Improving Antibody Drug Candidate Success Through Developability Assessments

Learn about tools and techniques used by AlivaMab Discovery Services to de-risk the transition from discovery to development.


Maximizing Efficiencies and De-Risking Lead Selection in Antibody Drug Discovery

Learn how AlivaMab Discovery Services and Ablexis’ AlivaMab® Mouse accelerate antibody drug discovery and development.


Upcoming Events

PEGS Europe

November 2-4, 2021

Learn More

Festival of Biologics Basel

November 9-11, 2021

Learn More

Antibody Engineering & Therapeutics

December 12-16, 2021

Learn More

Features & Interviews

Profile from Nature’s BioPharma Dealmakers September 2021

Ablexis and AlivaMab Discovery Services. Unparalleled success in antibody discovery and development.


Pharmaceutical Executive speaks with Larry Green

From Mouse to Mab


Nature speaks to Larry Green, Founder and Executive Chairman

Harnessing platform technology and expertise to fuel antibody drug discovery